05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
In a wrongful death suit by a Massachusetts wife of a man and their child who drowned in a Montreal ...
Read More >
This update provides an overview of key regulatory developments in the past three months relevant to...
Read More >
Robbie Hardy spent decades climbing the corporate ladder and being the only woman in the room. When ...
Read More >
Texas does not require private employers to provide paid sick leave to any employee. However, three ...
Read More >
Seyfarth Synopsis: As we reported here, the CBD (cannabidiol) craze is sweeping the nation. By 2022,...
Read More >
It can take almost a lifetime to build a sterling reputation in the retirement plan industry as a pl...
Read More >